"Least Burdensome" Reviews To Be Focus Of January FDA/Industry Meeting
This article was originally published in The Gray Sheet
Executive Summary
FDA is planning to hold a meeting with industry on Jan. 4 to discuss how the agency can best fulfill the "least burdensome" charge under the FDA Modernization Act.